More than $13 billion in venture capital poured into the economy in the second quarter of 2014, and about $2.7 billion was invested in 161 deals across the health care sector, according to a new report by CB Insights.
All told, health care IPOs accounted for nearly 50% of venture-backed IPO activity in the second quarter.
According to MedCity News, some of the largest IPOs of the quarter included:
- Adeptus Health, the parent company of the nation's largest freestanding ED network;
- Kite Pharma, which focuses on developing therapies for cancer care, raised $106 million in its public debut; and
- ZS Pharma, which is developing new treatments for kidney, cardiovascular, liver, and metabolic disorders and is expected to raise $107 million.Toolkit
The largest health care deals inked were for growth-stage companies, according to MedCity News. For instance, Intarcia Therapeutics raised $200 million to develop its Phase 3 drug to treat individuals with longstanding Type 2 diabetes. In addition, population health company Alignment Healthcare raised $125 million and gene therapy company Spark Therapeutics raised $73 million in a Series B funding round.
Why health systems are launching venture capital funds
In total, Series B deals rose to 30% during the second quarter, led by Avalanche Biotechnologies ($55 million), Principia Biopharma ($50 million), and Spark. In addition, Series D funding rose to 15% during the second quarter, compared with 8% during quarter one (Baum, MedCity News, 7/10)
Next in the Daily Briefing
Are hospitals doing enough to protect patients from fires?